These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 2847206)
61. Diurnal and circannual variation in platelet 3H-imipramine binding: comparative data on normal and affectively ill subjects. Baron M; Barkai A; Kowalik S; Fieve RR; Quitkin F; Gruen R Neuropsychobiology; 1988; 19(1):9-11. PubMed ID: 2847077 [TBL] [Abstract][Full Text] [Related]
62. Seasonal rhythm of platelet 3H-imipramine binding in normal controls. DeMet EM; Chicz-DeMet A; Fleischmann J Biol Psychiatry; 1989 Sep; 26(5):489-95. PubMed ID: 2551400 [TBL] [Abstract][Full Text] [Related]
63. Changes in platelet 3H-imipramine binding with chronic imipramine treatment are not state-dependent. DeMet EM; Gerner RH; Bell KM; Kauffmann CD; Chicz-DeMet A; Warren S Biol Psychiatry; 1989 Sep; 26(5):478-88. PubMed ID: 2551399 [TBL] [Abstract][Full Text] [Related]
64. Brain and brain monoamine oxidase in aging and in dementia of Alzheimer's type. Oreland L; Gottfries CG Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):533-40. PubMed ID: 3797686 [TBL] [Abstract][Full Text] [Related]
65. Effects of antidepressant treatments on platelet tritiated imipramine binding in major depressive disorder. Wägner A; Aberg-Wistedt A; Asberg M; Bertilsson L; Mårtensson B; Montero D Arch Gen Psychiatry; 1987 Oct; 44(10):870-7. PubMed ID: 2821953 [TBL] [Abstract][Full Text] [Related]
67. Selective breeding in rats for extreme densities of platelet 3H-imipramine binding sites: evidence against a trait hypothesis. Gentsch C; Lichtsteiner M; Feer H Psychiatry Res; 1989 Mar; 27(3):287-95. PubMed ID: 2540503 [TBL] [Abstract][Full Text] [Related]
68. Serotonin uptake and imipramine binding in the blood platelets of obsessive-compulsive disorder patients. Bastani B; Arora RC; Meltzer HY Biol Psychiatry; 1991 Jul; 30(2):131-9. PubMed ID: 1655071 [TBL] [Abstract][Full Text] [Related]
69. Platelet monoamine oxidase activity in subgroups of schizophrenic disorders. Schildkraut JJ; Orsulak PJ; Schatzberg AF; Herzog JM Schizophr Bull; 1980; 6(2):220-5. PubMed ID: 7375853 [TBL] [Abstract][Full Text] [Related]
70. Platelet MAO-B activity and serotonin content in patients with dementia: effect of age, medication, and disease. Mészáros Z; Borcsiczky D; Máté M; Tarcali J; Szombathy T; Tekes K; Magyar K Neurochem Res; 1998 Jun; 23(6):863-8. PubMed ID: 9572675 [TBL] [Abstract][Full Text] [Related]
71. Platelet [3H]imipramine binding in migraine and tension headache in relation to depression. Jarman J; Davies PT; Fernandez M; Glover V; Steiner TJ; Rose FC; Sandler M J Psychiatr Res; 1991; 25(4):205-11. PubMed ID: 1663998 [TBL] [Abstract][Full Text] [Related]
72. Laterality and 3H-imipramine binding: studies in the frontal cortex of normal controls and suicide victims. Arora RC; Meltzer HY Biol Psychiatry; 1991 May; 29(10):1016-22. PubMed ID: 1648414 [TBL] [Abstract][Full Text] [Related]
73. Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects. Kamal LA; Raisman R; Meyer P; Langer SZ Life Sci; 1984 May; 34(21):2083-8. PubMed ID: 6328154 [TBL] [Abstract][Full Text] [Related]
74. Up-regulatory effect of triphasic oral contraceptive on platelet 3H-imipramine binding sites. Weizman A; Morgenstern H; Kaplan B; Amiri Z; Tyano S; Ovadia Y; Rehavi M Psychiatry Res; 1988 Jan; 23(1):23-9. PubMed ID: 2834763 [TBL] [Abstract][Full Text] [Related]
75. Tritiated imipramine binding to platelets in manic subjects. Lewis DA; McChesney C J Affect Disord; 1985 Nov; 9(3):207-11. PubMed ID: 3001164 [TBL] [Abstract][Full Text] [Related]
77. Platelet imipramine binding and plasma cortisol levels in Israeli civilians during the Gulf War. Weizman R; Gil-Ad I; Karp L; Laor N; Barber Y; Rehavi M Biol Psychiatry; 1992 Jul; 32(2):170-8. PubMed ID: 1330007 [TBL] [Abstract][Full Text] [Related]
78. WHO pilot study on the validity of imipramine platelet receptor binding sites as a biological marker of endogenous depression. A preliminary report on the initial evaluation phase of a World Health Organization Collaborative Study. Bech P; Eplov L; Gastpar M; Gentsch C; Mendlewicz J; Plenge P; Rielaert C; Mellerup ET Pharmacopsychiatry; 1988 May; 21(3):147-50. PubMed ID: 2841696 [No Abstract] [Full Text] [Related]
79. The asymmetry of 3H-imipramine binding may predict psychiatric illness. Demeter E; Tekes K; Majorossy K; Palkovits M; Soós M; Magyar K; Somogyi E Life Sci; 1989; 44(19):1403-10. PubMed ID: 2541295 [TBL] [Abstract][Full Text] [Related]